TOMBESI PAOLO 4
4 · Turning Point Therapeutics, Inc. · Filed Jul 29, 2022
Insider Transaction Report
Form 4
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2022-07-27$74.94/sh−1,183$88,654→ 28,700 total
Footnotes (1)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021.